Article
Investigations of Interferon-Lambda for the Treatment of Cancer
6 Feb 2015
Abstract excerpt
Interferon-lambda (IFN-λ), a recently discovered cytokine, overlaps broadly with type I IFN signaling, producing antiviral, antiproliferative, and proapoptotic responses. In comparison to type I IFNs, IFN-λ has a limited spectrum of responsive tissues due to variation in expression of the IFN-λ receptor IFNLR1. Type I IFNs have been investigated for their antitumor effects and used in the clinical setting for a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
